Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Add-on to Telmisartan in CKD with Proteinuria
NCT03550859Phase 4Unknown
- Sponsor
- Yuhan
- Start
- Jun 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in chronic kidney disease (CKD), proteinuria, sponsored by Yuhan. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
chronic kidney disease (CKD)proteinuria
Beyond the preview
Go deeper on NCT03550859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550859.